Recognizing and Managing Iron Toxicity

Total Page:16

File Type:pdf, Size:1020Kb

Recognizing and Managing Iron Toxicity URGENT CARE Special Section Ferrous Sulfate Urgent Care Section Urgent Care 100 Tablets Recognizing and Managing Iron Toxicity Christian Balmadrid, MD Since urgent care physicians will encounter patients Senior Emergency Medicine Resident suffering from excess iron intake only occasionally, iron toxicity can be challenging when it does present. The Michael Bono, MD Professor of Emergency Medicine authors review the basic science and the signs, symptoms and course of illness and provide an update on the clinical Eastern Virginia Medical School Norfolk, Virginia management of these patients. © 2009 Punchstock 36 EMERGENCY MEDICINE | MAY 2009 www.emedmag.com IRON TOXICITY cute care settings form the first line of defense against the relatively un- TABLE 1. Common Iron Preparations common problem of toxicity from heavy metals and specifically from Compound Elemental iron Airon. If this illness presents to an urgent care ferrous sulfate 20% physician who has not maintained familiarity ferrous fumarate 33% with its effects and treatment, the potential for ferrous gluconate 12% morbidity and mortality due to misdiagnosis or inappropriate treatment is significant. ferric pyrophosphate 30% This article will review the basic science, the ferrocholinate 14% identifying signs and symptoms, and the prin- ferroglycine sulfate 16% ciples of clinical management applicable to pa- ferrous sulfate, dried 33% tients suffering from iron toxicity. We hope our ferrous carbonate, anhydrous 38% discussion will help you to be optimally prepared to provide their care, but the relatively low in- carbonyl iron 100% cidence of the diagnosis tends to make these Data extracted from: Velez LI and Delaney KA.4 cases challenging by nature. It is strongly recom- mended that a toxicologist or the regional poison control center always be consulted for suspected poisoning from iron or any other metal. an essential cofactor in the normal function of he- Section Urgent Care moglobin, myoglobin, cytochromes, and numer- CAUSES AND PATTERNS ous other catalytic enzymes. It is absorbed through OF IRON TOXICITY the digestive tract, then bound to transferrin in the Reports of iron exposure collected by the bloodstream. Normally, 15% to 35% of transfer- American Association of Poison Control Centers rin’s iron binding capacity is utilized.4 Overdoses (AAPCC) totaled approximately 35,000 in 2004.1 of iron, however, can quickly lead to transferrin More than 100 iron-containing preparations are saturation, resulting in free iron circulating in the listed in the Physicians’ Desk Reference, but the serum, which is directly toxic to organs. vast majority of cases in 2004 were, as usual, a The toxicity of iron depends on the amount of result of iron-containing multivitamin ingestions.1 elemental iron the ingested formulation contains. Unintentional ingestions by children younger than Some common iron preparations are listed in 6 years accounted for 83% of those reported cases, Table 14 and the elemental iron content of some while intentional overdoses (suicide attempts) popular multivitamin and were much more common in adults.1 Although prenatal vitamin formu- >>FAST TRACK<< intentional overdose accounted for only a small lations on the market is In children, poisonings fraction of the cases, it accounted for the majority shown in Table 2.2 While are usually the result of the admissions (58%), and resulted in a much the minimum toxic dose of ingestion of adult higher mortality rate (10% vs 1%).2 In children, and the lethal dose of iron formulations, especially pediatric multivitamin formulations are usually are not firmly established, prenatal vitamins. minimally toxic, and life-threatening poisonings it can be expected that in- are usually the result of ingestion of more potent gestion of less than 20 mg/kg of elemental iron will adult formulations, especially prenatal vitamins, usually cause no symptoms, 20 to 40 mg/kg will which have the highest iron content. In one case produce mild toxicity, 40 to 60 mg/kg will provoke control study, the birth of a sibling within 6 months moderate symptoms, and levels greater than 60 was identified as a risk factor for iron ingestion in mg/kg can lead to severe toxicity.4 children less than 3 years old.3 Iron is an essential metal, meaning it is an ele- COURSE OF ILLNESS ment that the body needs but does not produce Iron has two distinct toxic effects. First, it is di- and must extract from dietary sources. It acts as rectly caustic to the GI mucosa, leading to vom- www.emedmag.com MAY 2009 | EMERGENCY MEDICINE 37 IRON TOXICITY iting, diarrhea, and abdominal pain. In severe cases, it can re- TABLE 2. Elemental Iron Content of Select sult in hemorrhagic necrosis with Multivitamin Formulations bleeding, perforation, and peritoni- tis. Second, it impairs intracellular Preparation Elemental iron metabolism, primarily through PRENATAL VITAMINS lipid peroxidation and free radical formation. One of its most impor- NataChew Prenatal Vitamins 29 mg tant consequences is impairment of Natalins Rx 60 mg adenosine triphosphate synthesis, Natalins 45 mg which results from alteration of the CHILDREN’S MULTIVITAMINS lipid membrane of mitochondria, inhibition of enzymatic processes Bugs Bunny With Iron 18 mg in the Krebs cycle, and uncoupling Centrum Jr. Plus Iron 18 mg of oxidative phosphorylation.2,4 Centrum Kids Complete Rugrats® 18 mg In addition to its effects at the Flintstones® With Iron 18 mg cellular level, iron also acts as a di- Poly-Vi-Sol With Iron rect vasodilator, can increase cap- illary permeability, and is directly Tablet 12 mg toxic to the myocardium.2 These Drops 10 mg/mL effects, in addition to the severe Shamu and His Crew® Plus Iron 18 mg GI fluid losses that occur from the Sunkist® Complete 18 mg vomiting and diarrhea, can lead to shock in severe cases.4 ADULT MULTIVITAMINS Depending on the source, acute Centrum® 18 mg iron toxicity is typically described Centrum® Silver 4 mg in four or five stages. Signs and Complete for Men 5 mg symptoms may overlap, however. Complete for Women 10 mg As noted for each below, there is a Urgent Care Section Urgent Care classical timeline for these symp- Natural MD toms, but it may be quite acceler- Men/Basic Life Prescription 5 mg ated with larger ingestions. Women/Basic Life Prescription 5 mg Stage 1: Gastrointestinal ef- Women/Standard Life Prescription 10 mg fects, 30 minutes to 6 hours. One-A-Day® Maximum 18 mg Stage 1 is characterized primarily ® by GI effects, and is the result of One-A-Day Women’s 27 mg iron’s direct toxic effects on the GI Stresstabs® Plus Iron 18 mg mucosa. Vomiting will usually oc- cur within the first 1 to 1.5 hours Data extracted from: Liebelt LL and Kronfol R.2 following the ingestion in severe toxicity, but may be delayed up to 6 hours with enteric-coated iron tablets. Vomiting and if a patient remains asymptomatic for 6 hours is the most sensitive indicator of severe toxicity. after a presumed iron ingestion, it is unlikely that Other symptoms can include abdominal pain, di- any serious side effects will occur (again, unless arrhea, hematemesis, melena, and lethargy. Lab enteric coated iron tablets were ingested, which results will show a metabolic acidosis. If death may have delayed effects).2,4 occurs in this stage, it is usually secondary to hy- Stage 2: Latent phase, 6 to 24 hours. This is a povolemic shock. Patients with mild to moderate period of apparent recovery in which the patient’s toxicity usually will not progress beyond Stage 1, GI symptoms have resolved because the circulat- 38 EMERGENCY MEDICINE | MAY 2009 www.emedmag.com IRON TOXICITY ing free iron has redistributed into the reticuloen- dothelial system, where it no longer produces its TABLE 3. Peak Serum Iron in toxic GI effects. In severe toxicity, this stage may Correlation with Toxicity not occur at all. The challenge, clinically, is to dis- tinguish between the patient in a true latent phase Peak serum iron (μg/dL) Toxicity that may progress to more serious stages and the 50-150 none patient who only had mild GI toxicity that has now 150-300 mild resolved. Careful examination and assessment may produce clues. Although patients in the latent 300-500 moderate (rarely develop serious complications) phase may appear stable, they are not necessarily asymptomatic. There may still be poor perfusion, >500 severe (serious systemic toxicity) hyperventilation (secondary to metabolic acidosis), or oliguria (secondary to hypovolemia).2,4 >1000 significant morbidity and mortality Stage 3: Shock and metabolic acidosis, 6 to 72 hours. Patients will have severe metabolic aci- Data extacted from: Liebelt LL and Kronfol R2; Velez LI and dosis in this stage, partly as a result of hydration Delaney KA.4 of absorbed ferric ions, which releases hydrogen ions as a by-product of the reaction.2 Additionally, lactic acidosis results secondary to hypovolemia from Stage 1 may recur within the first few hours, and poor tissue perfusion as well as iron-induced resulting in further hypovolemia and hypovole- Section Urgent Care mitochondrial dysfunction.2 mic shock. A few hours later, distributive shock Different types of shock may occur in this may occur secondary to iron’s effect as a vasodi- stage, including hypovolemic, distributive, and lator and its tendency to increase vascular perme- cardiogenic shock. Gastrointestinal symptoms ability. Also of concern is iron’s direct toxicity to www.emedmag.com MAY 2009 | EMERGENCY MEDICINE 39 IRON TOXICITY the myocardium, which may lead to cardiogenic The most useful laboratory value to follow in shock within 1 to 2 days.2 acute iron toxicity is the serum iron level. Peak Other symptoms at this stage may include GI serum iron levels usually correlate with toxicity as hemorrhage, bowel perforation, iron-induced co- shown in Table 3.2,4 It is important to note, how- agulopathy (iron causes thrombin dysfunction), ever, that measurements of serum iron level reflect renal and hepatic dysfunction (leading to jaun- free iron circulating in the blood.
Recommended publications
  • HISTORY of LEAD POISONING in the WORLD Dr. Herbert L. Needleman Introduction the Center for Disease Control Classified the Cause
    HISTORY OF LEAD POISONING IN THE WORLD Dr. Herbert L. Needleman Introduction The Center for Disease Control classified the causes of disease and death as follows: 50 % due to unhealthy life styles 25 % due to environment 25% due to innate biology and 25% due to inadequate health care. Lead poisoning is an environmental disease, but it is also a disease of life style. Lead is one of the best-studied toxic substances, and as a result we know more about the adverse health effects of lead than virtually any other chemical. The health problems caused by lead have been well documented over a wide range of exposures on every continent. The advancements in technology have made it possible to research lead exposure down to very low levels approaching the limits of detection. We clearly know how it gets into the body and the harm it causes once it is ingested, and most importantly, how to prevent it! Using advanced technology, we can trace the evolution of lead into our environment and discover the health damage resulting from its exposure. Early History Lead is a normal constituent of the earth’s crust, with trace amounts found naturally in soil, plants, and water. If left undisturbed, lead is practically immobile. However, once mined and transformed into man-made products, which are dispersed throughout the environment, lead becomes highly toxic. Solely as a result of man’s actions, lead has become the most widely scattered toxic metal in the world. Unfortunately for people, lead has a long environmental persistence and never looses its toxic potential, if ingested.
    [Show full text]
  • Pharmacology/Therapeutics Ii Block 1 Handouts – 2015-16
    PHARMACOLOGY/THERAPEUTICS II BLOCK 1 HANDOUTS – 2015‐16 55. H2 Blockers, PPls – Moorman 56. Palliation of Contipation & Nausea/Vomiting – Kristopaitis 57. On‐Line Only – Principles of Clinical Toxicology – Kennedy 58. Anti‐Parasitic Agents – Johnson Histamine Antagonists and PPIs January 6, 2016 Debra Hoppensteadt Moorman, Ph.D. Histamine Antagonists and PPIs Debra Hoppensteadt Moorman, Ph.D. Office # 64625 Email: [email protected] KEY CONCEPTS AND LEARNING OBJECTIVES . 1 To understand the clinical uses of H2 receptor antagonists. 2 To describe the drug interactions associated with the use of H2 receptor antagonists. 3 To understand the mechanism of action of PPIs 4 To describe the adverse effects and drugs interactions with PPIs 5 To understand when the histamine antagonists and the PPIs are to be used for treatment 6 To describe the drugs used to treat H. pylori infection Drug List: See Summary Table. Histamine Antagonists and PPIs January 6, 2016 Debra Hoppensteadt Moorman, Ph.D. Histamine Antagonists and PPIs I. H2 Receptor Antagonists These drugs reduce gastric acid secretion, and are used to treat peptic ulcer disease and gastric acid hypersecretion. These are remarkably safe drugs, and are now available over the counter. The H2 antagonists are available OTC: 1. Cimetidine (Tagamet®) 2. Famotidine (Pepcid®) 3. Nizatidine (Axid®) 4. Ranitidine (Zantac®) All of these have different structures and, therefore, different side-effects. The H2 antagonists are rapidly and well absorbed after oral administration (bioavailability 50-90%). Peak plasma concentrations are reached in 1-3 hours, and the drugs have a t1/2 of 1-3 hours. H2 antagonists also inhibit stimulated (due to feeding, gastrin, hypoglycemia, vagal) acid secretion and are useful in controlling nocturnal acidity – useful when added to proton pump therapy to control “nocturnal acid breakthrough”.
    [Show full text]
  • Poisoning in Children
    ARTICLE IN PRESS Current Paediatrics (2005) 15, 563–568 www.elsevier.com/locate/cupe Poisoning in children Fiona JepsenÃ, Mary Ryan Emergency Medicine, Royal Liverpool Children’s NHS Trust, Alder Hey, Liverpool L12 2AP, UK KEYWORDS Summary Poisoning accounts for about 7% of all accidents in children under 5 Poisoning; years and is implicated in about 2% of all childhood deaths in the developed world, Child; and over 5% in the developing world (National Poisons Information Service). In Accidents; considering this topic, however, it is important to differentiate accidental overdose Home (common in the younger age groups) and deliberate overdose (more common in young adults). Although initial assessment and treatment of these groups may not differ significantly, the social issues and ongoing follow-up of these children will be totally different and the treating physician must remain aware of this difference. The initial identification and treatment of these children remains the mainstay of management, and many ingested substances do not have a specific antidote. Supportive treatment must be planned and the potential for delayed or long-term effects noted. The specific presentation and treatment of some of the commonly ingested substances will be addressed in this article, and guidance given on when to contact expert help. & 2005 Elsevier Ltd. All rights reserved. Introduction such as bleaches, detergents and turpentine sub- stitutes. More than 100 000 individuals are admitted to Toxic compounds may be ingested or inhaled hospital in England and Wales annually due to either accidentally or deliberately. Accidental poisoning, accounting for 10% of all acute admis- poisoning can occur at any age, but is much more 1 sions.1 However, the true incidence of acute common in children.
    [Show full text]
  • Acute Poisoning: Understanding 90% of Cases in a Nutshell S L Greene, P I Dargan, a L Jones
    204 REVIEW Postgrad Med J: first published as 10.1136/pgmj.2004.027813 on 5 April 2005. Downloaded from Acute poisoning: understanding 90% of cases in a nutshell S L Greene, P I Dargan, A L Jones ............................................................................................................................... Postgrad Med J 2005;81:204–216. doi: 10.1136/pgmj.2004.024794 The acutely poisoned patient remains a common problem Paracetamol remains the most common drug taken in overdose in the UK (50% of intentional facing doctors working in acute medicine in the United self poisoning presentations).19 Non-steroidal Kingdom and worldwide. This review examines the initial anti-inflammatory drugs (NSAIDs), benzodiaze- management of the acutely poisoned patient. Aspects of pines/zopiclone, aspirin, compound analgesics, drugs of misuse including opioids, tricyclic general management are reviewed including immediate antidepressants (TCAs), and selective serotonin interventions, investigations, gastrointestinal reuptake inhibitors (SSRIs) comprise most of the decontamination techniques, use of antidotes, methods to remaining 50% (box 1). Reductions in the price of drugs of misuse have led to increased cocaine, increase poison elimination, and psychological MDMA (ecstasy), and c-hydroxybutyrate (GHB) assessment. More common and serious poisonings caused toxicity related ED attendances.10 Clinicians by paracetamol, salicylates, opioids, tricyclic should also be aware that severe toxicity can result from exposure to non-licensed pharmaco-
    [Show full text]
  • Toxicity Forecaster (Toxcasttm)
    science in ACTION www.epa.gov/research INNOVATIVE RESEARCH FOR A SUSTAINABLE FUTURE Toxicity Forecaster (ToxCastTM) ADVANCING THE NEXT GENERATION OF CHEMICAL SAFETY EVALUATION Tens of thousands of chemicals are currently in commerce, and hundreds more are introduced every year. Because current chemical testing is expensive and time consuming, only a small fraction of chemicals have been fully evaluated for potential human health effects. Through its computational toxicology research (CompTox), the U.S. Environmental Protection Agency (EPA) is working to figure out how to change the current approach used to evaluate the safety of chemicals. CompTox research integrates advances in biology, biotechnology, chemistry, and computer science to identify important biological processes that may be disrupted by the chemicals and tracing those biological the potential to limit the number of of sources; including industrial and disruptions to a related dose and required laboratory animal-based consumer products, food additives, human exposure. The combined toxicity tests while quickly and and potentially “green” chemicals information helps prioritize efficiently screening large numbers that could be safer alternatives to chemicals based on potential human of chemicals. existing chemicals. These 2,000 health risks. Using CompTox, chemicals were evaluated in over thousands of chemicals can be The first phase of ToxCast, 700 high-throughput assays that evaluated for potential risk at a small appropriately called “Proof of cover a range of high-level cell cost in a very short amount of time. Concept”, was completed in responses and approximately 2009 and it evaluated over 300 300 signaling pathways. ToxCast A major part of EPA’s CompTox well studied chemicals (primarily research is the Toxicity Forecaster research is ongoing to determine pesticides) in over 500 high- which assays under what conditions (ToxCast™).
    [Show full text]
  • TOXICOLOGY and EXPOSURE GUIDELINES ______(For Assistance, Please Contact EHS at (402) 472-4925, Or Visit Our Web Site At
    (Revised 1/03) TOXICOLOGY AND EXPOSURE GUIDELINES ______________________________________________________________________ (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) "All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy." This early observation concerning the toxicity of chemicals was made by Paracelsus (1493- 1541). The classic connotation of toxicology was "the science of poisons." Since that time, the science has expanded to encompass several disciplines. Toxicology is the study of the interaction between chemical agents and biological systems. While the subject of toxicology is quite complex, it is necessary to understand the basic concepts in order to make logical decisions concerning the protection of personnel from toxic injuries. Toxicity can be defined as the relative ability of a substance to cause adverse effects in living organisms. This "relative ability is dependent upon several conditions. As Paracelsus suggests, the quantity or the dose of the substance determines whether the effects of the chemical are toxic, nontoxic or beneficial. In addition to dose, other factors may also influence the toxicity of the compound such as the route of entry, duration and frequency of exposure, variations between different species (interspecies) and variations among members of the same species (intraspecies). To apply these principles to hazardous materials response, the routes by which chemicals enter the human body will be considered first. Knowledge of these routes will support the selection of personal protective equipment and the development of safety plans. The second section deals with dose-response relationships.
    [Show full text]
  • Ethylene Glycol Ingestion Reviewer: Adam Pomerlau, MD Authors: Jeff Holmes, MD / Tammi Schaeffer, DO
    Pediatric Ethylene Glycol Ingestion Reviewer: Adam Pomerlau, MD Authors: Jeff Holmes, MD / Tammi Schaeffer, DO Target Audience: Emergency Medicine Residents, Medical Students Primary Learning Objectives: 1. Recognize signs and symptoms of ethylene glycol toxicity 2. Order appropriate laboratory and radiology studies in ethylene glycol toxicity 3. Recognize and interpret blood gas, anion gap, and osmolal gap in setting of TA ingestion 4. Differentiate the symptoms and signs of ethylene glycol toxicity from those associated with other toxic alcohols e.g. ethanol, methanol, and isopropyl alcohol Secondary Learning Objectives: detailed technical/behavioral goals, didactic points 1. Perform a mental status evaluation of the altered patient 2. Formulate independent differential diagnosis in setting of leading information from RN 3. Describe the role of bicarbonate for severe acidosis Critical actions checklist: 1. Obtain appropriate diagnostics 2. Protect the patient’s airway 3. Start intravenous fluid resuscitation 4. Initiate serum alkalinization 5. Initiate alcohol dehydrogenase blockade 6. Consult Poison Center/Toxicology 7. Get Nephrology Consultation for hemodialysis Environment: 1. Room Set Up – ED acute care area a. Manikin Set Up – Mid or high fidelity simulator, simulated sweat if available b. Airway equipment, Sodium Bicarbonate, Nasogastric tube, Activated charcoal, IV fluid, norepinephrine, Simulated naloxone, Simulate RSI medications (etomidate, succinylcholine) 2. Distractors – ED noise For Examiner Only CASE SUMMARY SYNOPSIS OF HISTORY/ Scenario Background The setting is an urban emergency department. This is the case of a 2.5-year-old male toddler who presents to the ED with an accidental ingestion of ethylene glycol. The child was home as the father was watching him. The father was changing the oil on his car.
    [Show full text]
  • Critical Care Nursing of Infants and Children Martha A
    University of Pennsylvania ScholarlyCommons Miscellaneous Papers Miscellaneous Papers 1-1-2001 Critical Care Nursing of Infants and Children Martha A. Q. Curley University of Pennsylvania, [email protected] Patricia A. Moloney-Harmon The Children's Hospital at Sinai Copyright by the author. Reprinted from Critical Care Nursing of Infants and Children, Martha A.Q. Curley and Patricia A. Moloney-Harmon (Editors), (Philadelphia: W.B. Saunders Co., 2001), 1,128 pages. NOTE: At the time of publication, the author, Martha Curley was affiliated with the Children's Hospital of Boston. Currently, she is a faculty member in the School of Nursing at the University of Pennsylvania. This paper is posted at ScholarlyCommons. http://repository.upenn.edu/miscellaneous_papers/4 For more information, please contact [email protected]. Please Note: The full version of this book and all of its chapters (below) can be found on ScholarlyCommons (from the University of Pennsylvania) at http://repository.upenn.edu/miscellaneous_papers/4/ Information page in ScholarlyCommons Full book front.pdf - Front Matter, Contributors, Forward, Preface, Acknowledgements, and Contents Chapter 1.pdf - The Essence of Pediatric Critical Care Nursing Chapter 2.pdf - Caring Practices: Providing Developmentally Supportive Care Chapter_3.pdf - Caring Practices: The Impact of the Critical Care Experience on the Family Chapter_4.pdf - Leadership in Pediatric Critical Care Chapter 5.pdf - Facilitation of Learning Chapter_6.pdf - Advocacy and Moral Agency: A Road Map for
    [Show full text]
  • Chelation Therapy
    Corporate Medical Policy Chelation Therapy File Name: chelation_therapy Origination: 12/1995 Last CAP Review: 2/2021 Next CAP Review: 2/2022 Last Review: 2/2021 Description of Procedure or Service Chelation therapy is an established treatment for the removal of metal toxins by converting them to a chemically inert form that can be excreted in the urine. Chelation therapy comprises intravenous or oral administration of chelating agents that remove metal ions such as lead, aluminum, mercury, arsenic, zinc, iron, copper, and calcium from the body. Specific chelating agents are used for particular heavy metal toxicities. For example, desferroxamine (not Food and Drug Administration [FDA] approved) is used for patients with iron toxicity, and calcium-ethylenediaminetetraacetic acid (EDTA) is used for patients with lead poisoning. Note that disodium-EDTA is not recommended for acute lead poisoning due to the increased risk of death from hypocalcemia. Another class of chelating agents, called metal protein attenuating compounds (MPACs), is under investigation for the treatment of Alzheimer’s disease, which is associated with the disequilibrium of cerebral metals. Unlike traditional systemic chelators that bind and remove metals from tissues systemically, MPACs have subtle effects on metal homeostasis and abnormal metal interactions. In animal models of Alzheimer’s disease, they promote the solubilization and clearance of β-amyloid protein by binding to its metal-ion complex and also inhibit redox reactions that generate neurotoxic free radicals. MPACs therefore interrupt two putative pathogenic processes of Alzheimer’s disease. However, no MPACs have received FDA approval for treating Alzheimer’s disease. Chelation therapy has also been investigated as a treatment for other indications including atherosclerosis and autism spectrum disorder.
    [Show full text]
  • Small Dose... Big Poison
    Traps for the unwary George Braitberg Ed Oakley Small dose... Big poison All substances are poisons; Background There is none which is not a poison. It is not possible to identify all toxic substances in a single The right dose differentiates a poison from a remedy. journal article. However, there are some exposures that in Paracelsus (1493–1541)1 small doses are potentially fatal. Many of these exposures are particularly toxic to children. Using data from poison control centres, it is possible to recognise this group of Poisoning is a frequent occurrence with a low fatality rate. exposures. In 2008, almost 2.5 million human exposures were reported to the National Poison Data System (NPDS) in the United Objective States, of which only 1315 were thought to contribute This article provides information to assist the general to fatality.2 The most common poisons associated with practitioner to identify potential toxic substance exposures in children. fatalities are shown in Figure 1. Polypharmacy (the ingestion of more than one drug) is far more common. Discussion In this article the authors report the signs and symptoms Substances most frequently involved in human exposure are shown of toxic exposures and identify the time of onset. Where in Figure 2. In paediatric exposures there is an over-representation clear recommendations on the period of observation and of personal care products, cleaning solutions and other household known fatal dose are available, these are provided. We do not discuss management or disposition, and advise readers products, with ingestions peaking in the toddler age group. This to contact the Poison Information Service or a toxicologist reflects the acquisition of developmental milestones and subsequent for this advice.
    [Show full text]
  • Effects of Temperature and Storage Conditions on the Electrophoretic, Toxic and Enzymatic Stability of Venom Components Sean M
    Comp. Biochem. Physiol. Vol. 119B, No. 1, pp. 119±127, 1998 ISSN 0305-0491/98/$19.00 Copyright 1998 Elsevier Science Inc. All rights reserved. PII S0305-0491(97)00294-0 Effects of Temperature and Storage Conditions on the Electrophoretic, Toxic and Enzymatic Stability of Venom Components Sean M. Munekiyo and Stephen P. Mackessy Department of Biological Sciences, 501 20th St., University of Northern Colorado, Greeley, CO 80639, U.S.A. ABSTRACT. Rattlesnake venoms are complex biological products containing potentially autolytic compo- nents, and they provide a useful tool for the study of long-term maintenance of enzymes in a competent state, both in vivo and in vitro. To evaluate the stability of venom components, 15 aliquots of freshly extracted venom (from Crotalus molossus molossus) were subjected to 15 different temperature and storage conditions for 1 week and then lyophilized; conditions varied from storage at 280°C (optimal preservation of activities) to dilution (1:24) and storage at 37°C (maximal degradation potential). Effects of different storage conditions were evalu- ated using SDS-PAGE, metalloprotease zymogram gels, a cricket LD50 assay and enzyme assays (metalloprotease, serine proteases, phosphodiesterase, l-amino acid oxidase and phospholipase A2). Venom samples were remark- ably refractive to widely varying conditions; enzyme activities of some samples were variable, particularly l- amino acid oxidase, and one sample treatment showed higher toxicity, but electrophoretic results indicated very little effect on venom proteins. This study suggests that most venom activities should remain stable even if stored or collected under potentially adverse conditions, and freezing samples is not necessarily advantageous.
    [Show full text]
  • From Murder to Mechanisms 7000 Years of Toxicology's Evolution
    From Murder to Mechanisms 7000 Years of Toxicology’s Evolution 7000 Years of Toxicology’s Evolution Michael A. Gallo, PhD, DABT (ret), Emeritus Fellow ATS Professor Emeritus Environmental and Occupational Health Sciences Institute Rutgers-Robert Wood Johnson Medical School Piscataway, New Jersey Toxicants: Friends or Foes? “The dose makes the poison” Paracelsus 1493-1541 Objectives This presentation provides a history of toxicology with a few classic examples. The Family of Toxicology Poisons Signs, Symptoms, Adverse Reactions & Antidotes Drugs Patent Medicines and Chemotherapeutics Food Natural toxicants Industrial Chemicals Occupational and Environmental Toxicity Safety Evaluation Hazard Identification Tools to Elucidate Biology Toxicology the Borrowing Science • Pharmacology • Pathology • Physiology • Biochemistry • Synthetic Chemistry • Analytical Chemistry • Molecular and Cellular Biology • High Resolution Imaging Earliest Humans* • Use of natural toxins • Oral history evolved • Animal venoms • Toxic metals • Plant extracts – Hunting* – Warfare – Assassination * still used by indigenous people in S. America, Borneo, Pacific Islanders Ebers Papyrus ~1500 BCE • Hemlock • Aconite (buttercup family) • Opium • Lead • Copper • Antimony • Venoms Hippocrates and Friends • Defined effective dosages of toxin • Described bioavailability • Theophastus (370-286 BCE) – De Historia Plantanum • Socrates- Hemlock • Dioscorides (Nero)poison classes through 19th • Discovery of BellaDonna (scopolamine) • Discovery of Digitalis (foxglove)Dioscorides
    [Show full text]